Stock screenerAll disclosures →
EDGAR →
CANF
Conviction 39HealthcareScan · Mon, Aug 10, 2026CANF$3.33-3.20%
ResistanceSupportVol 14Vol MA14 33.23K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Can-Fite BioPharma Ltd.www.canfite.com ↗
Price3.33
Change-3.20%
Gap-2.91%
Rel volume0.00×
Avg volume104K
Avg $ vol338.61K
SMA 203.27
SMA 503.21
SMA 2002.76
Price vs 50+3.71%
Price vs 200+20.49%
MA stackbullish
50/200 cross—
Supertrenddown · 3.83
RSI (14)52
MACD hist0.02
MACD crossbull · 2d
Stoch %K / %D43 / 67
ADX (14)41
+DI / −DI30 / 11
RSI divergence—
MACD divergence—
ATR %+6.71%
ADR %4.70%
52w high6.02
52w low0.1715
From 52w high-44.68%
Above 52w low+1841.69%
New 52w highNo
SqueezeOn · 7d
Bollinger width13.05%
%B0.63
Donchian pos42.55%
Donchian high3.60
Donchian low3.13
AVWAP (52w high)4.80
vs AVWAP high-30.57%
AVWAP (52w low)4.34
vs AVWAP low-23.25%
OBV trendDown
Chaikin MF (20)-0.48
Today vs 20d0.00×
Avg vol (14d)33.23K
Avg vol (20d)104K
Avg $ vol (20d)338.61K
Market cap8.72M
RS 3m (vs SPY)-8.52%
RS 6m (vs SPY)-33.17%
RS line new highNo
Trend template4/8
Technical rank55.5
1 week+5.05%
1 month+2.46%
3 months-5.13%
6 months-19.95%
1 year+379.14%
YTD+1413.64%
P/E—
P/B1.56
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current3.46
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value3.19M
Revenue—
Net income—
Gross profit—
Free cash flow—
Industry—
ExchangeNYSE
Shares out—
Employees5
ListedMon, Sep 10, 2012
Free float—
Float %—
Short interest110.19K
Days to cover0.0d
Short volume13.2%
Squeeze score0 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction39 / 100
Pattern quality—
Tech rank55.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.79
Support2.85
Days since event—
Candle confirm—
News sentiment—
Congress activity
Disclosed STOCK Act trades in CANF
No recent disclosed trades by Congress in CANF. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CANF · 2 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Farbstein Motti CEO, CFO and COO · Options to Purchase Ordinary Shares · 2026-06-04 | Grant | 24K | $0 | 2026-06-04 | 2026-06-08 |
Fishman Pnina Chief Scientific Officer · Options to Purchase Ordinary Shares · 2026-06-04 | Grant | 24K | $0 | 2026-06-04 | 2026-06-08 |
SEC filings
EDGAR filings in CANF · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.